SITC Archive Library

2014 Advances in Cancer Immunotherapy™ - Princeton, NJ 

03-26-2018 14:14

2014 Advances in Cancer Immunotherapy™ - Princeton, NJ
March 28, 2014
Princeton University
Princeton, NJ

Program Summary
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI)- La Jolla program enduring materials are provided here.

Upon completion of this program, the participants will be able to:

  1. Interpret the key principles of tumor immunology and immunotherapy
  2. Analyze recent research and clinical applications of cytokines, cancer vaccines, T cell checkpoint inhibitors, adoptive immunotherapy and biomarkers
  3. Participate in scientific exchange with local colleagues, potential collaborators, and subject matter experts on research and clinical application of cancer immunotherapy
  4. Implement cancer immunotherapy treatments into clinical practice more effectively through a sound understanding of how they work, the clinical management of patients, and the potential to improve patient outcomes with tumor immunotherapy
Organizers
Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey
Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center

Target Audience
The target audience for this program includes clinical oncologists, those involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn principles of tumor immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients.

#Biomarkers #ClinicalTrials #GenitourinaryCancers #ColonCancer #Melanoma #Non-SmallCellLungCancer
#BladderCancer #RenalCellCarcinoma #PresentationSlides #AdvancesinCancerImmunotherapy(ACI)
#SITC #CombinationTherapy #Cytokines #ImmuneCheckpointInhibitors #Ipilimumab #Nivolumab
#Pembrolizumab #Vaccines #AdverseEvents #AlliedHealth #Clinician #Industry #RegisteredNurse #Oncologist #2014

Statistics
0 Favorited
8 Views
9 Files
0 Shares
35 Downloads
Attachment(s)
pdf file
Immunology 101 for the Non-Immunologist - Presentation Sl...   1.87 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session I: Basic Principles of Tumor Immunology; Presentation: Immunology 101 for the Non-Immunologist; Presenter: Derek B. Sant'Angelo, PhD - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014
pdf file
Basic Principles of Tumor Immunology - Presentation Slides   1.64 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session I: Basic Principles of Tumor Immunology; Presentation: Basic Principles of Tumor Immunology; Presenter: Richard D. Carvajal, MD - Columbia University; Date: March 28, 2014
pdf file
Approved Agents, Drugs in Development and Combination St...   3.50 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session II: Major Approaches to Tumor Immunotherapy - What the Clinician Needs to Know; Presentation: Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies; Presenter: Jedd D. Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center; Date: March 28, 2014
pdf file
Oncolytic Viruses as Tumor Immunotherapy Agents - Present...   1.83 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session II: Major Approaches to Tumor Immunotherapy - What the Clinician Needs to Know; Presentation: Oncolytic Viruses as Tumor Immunotherapy Agents; Presenter: Howard L. Kaufman, MD, FACS - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014
pdf file
Is There a Role for Radiation Therapy and Immunotherapy -...   821 KB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session II: Major Approaches to Tumor Immunotherapy - What the Clinician Needs to Know; Presentation: Is There a Role for Radiation Therapy and Immunotherapy; Presenter: Salma K. Jabbour, MD - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014
pdf file
Interferons, Interleukins and Beyond - Presentation Slides   1.72 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session III: The Role of Tumor Immunotherapy for Cancer - Clinical Indications and Patient Management; Presentation: Cytokines: Interferons, Interleukins and Beyond; Presenter: Sanjiv S. Agarwala, Md - St. Luke's Cancer Center and Temple University; Date: March 28, 2014
pdf file
Immunotherapy for the Treatment of GU Malignancies - Pres...   2.79 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session III: The Role of Tumor Immunotherapy for Cancer - Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of GU Malignancies; Presenter: Eric Singer, MD - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014
pdf file
Immunotherapy for the Treatment of Melanoma - Presentatio...   2.41 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session III: The Role of Tumor Immunotherapy for Cancer - Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Janice M. Mehnert, MD - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014
pdf file
Immunotherapy for the Treatment of Brain Metastases - Pre...   1.43 MB   1 version
Uploaded - 03-26-2018
Meeting: Advances in Cancer Immunotherapy™- Princeton, NJ; Session III: The Role of Tumor Immunotherapy for Cancer - Clinical Indications and Patient Management; Presentation: Immunotherapy for the Treatment of Brain Metastases; Presenter: Ann W. Silk, MD, MS - Rutgers Cancer Institute of New Jersey; Date: March 28, 2014